Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Replacement Therapy Versus Placebo in Women With Stage I or II Endometrial Adenocarcinoma
NCT00002976Phase 3Terminated
- Sponsor
- GOG Foundation
- Start
- Jun 1997
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of conjugated estrogens in endometrial adenocarcinoma, sponsored by GOG Foundation. Started Jun 1997; status: terminated.
02
Drugs
conjugated estrogens
03
Conditions
endometrial adenocarcinoma
Beyond the preview
Go deeper on NCT00002976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002976.